C-134

Carisoprodol-¹³C₃ solution

100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant^®

• 經驗公式（希爾表示法）: C₉¹³C₃H₂₄N₂O₄
• 分子量：: 263.31
• EC號碼: 200-659-6
• 分類程式碼代碼: 41116107
• NACRES: NA.24

屬性

• 等級: certified reference material
• 品質等級: 300
• 形狀: liquid
• 特點: (Snap-N-Spike^®)
• 包裝: ampule of 1 mL
• 製造商／商標名: Cerilliant^®
• 濃度: 100 μg/mL in methanol
• 技術: gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• 應用: clinical testing
• 形式: single component solution
• 儲存溫度: −20°C

描述

一般說明

This stable-labeled internal standard is suitable for carisoprodol testing or isotope dilution methods by LC/MS or GC/MS for applications in forensic analysis, urine drug testing, clinical toxicology, or pain prescription monitoring. Sold under trade names such as Soma and Sanoma, carisoprodol is a skeletal muscle relaxant that is often abused recreationally. Carisoprodol is purportedly used by drug users to potentiate the effects of other narcotics.

應用

• Pharmacotherapy for Spine-Related Pain in Older Adults: This study explores various pharmacotherapeutic approaches, including Carisoprodol, for managing spine-related pain in older adults, emphasizing its efficacy and safety within geriatric care (Fu JL, Perloff MD, 2022).


• Rapid Extraction and Qualitative Screening of 30 Drugs in Oral Fluid: Demonstrates the application of Carisoprodol in forensic toxicology by detailing methods for rapid drug screening in oral fluid, specifically for driving under the influence of drugs (DUID) cases (Coulter C, Garnier M, Moore C, 2022).


• Single and Multiple Dose PK-PD Characterization for Carisoprodol: Discusses a clinical trial that characterizes the pharmacokinetics and pharmacodynamics of Carisoprodol in healthy volunteers, assessing the impact of the CYP2C19 phenotype on its metabolism (Calvo A, Alonso S, Prieto E, et al., 2022).


• Tizanidine: Advances in Pharmacology & Therapeutics and Drug Formulations: Although focusing on Tizanidine, this review touches upon comparative analysis with other muscle relaxants like Carisoprodol, providing insights into therapeutic advancements and formulation strategies (Zhu LL, Wang YH, Zhou Q, 2024).

法律資訊

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

安全資訊

• 象形圖: GHS02,GHS06,GHS08
• 訊號詞: Danger
• 危險聲明: H225,H301 + H311 + H331,H370
• 防範說明: P210 - P233 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311
• 危險分類: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
• 標靶器官: Eyes,Central nervous system
• 儲存類別代碼: 3 - Flammable liquids
• 水污染物質分類（WGK）: WGK 2
• 閃點（°F）: 49.5 °F - closed cup
• 閃點（°C）: 9.7 °C - closed cup